Cresco Labs (CRLBF) Total Non-Current Liabilities (2019 - 2026)

Cresco Labs (CRLBF) posted Total Non-Current Liabilities of $856.5 million for Q1 2026, up 1.4% on a QoQ basis from $844.6 million in Q4 2025, and down 2.15% year-over-year from $875.3 million in Q1 2025.

Cresco Labs (CRLBF) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Cresco Labs' Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $856.5 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 2.15% year-over-year to $856.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $856.5 million (down 2.15% YoY) and the FY2025 annual result came in at $844.6 million, down 3.23% from the prior year.
  • Total Non-Current Liabilities was $856.5 million for Q1 2026 at Cresco Labs, up from $844.6 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $885.5 million in Q2 2025 and bottomed at $689.2 million in Q2 2022.
  • A 5-year average of $784.0 million and a median of $740.1 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 64.23% — and 2025, when it fell 3.23%.
  • Cresco Labs' Total Non-Current Liabilities stood at $740.1 million in 2022, then fell by 1.35% to $730.2 million in 2023, then climbed by 19.54% to $872.8 million in 2024, then fell by 3.23% to $844.6 million in 2025, then climbed by 1.4% to $856.5 million in 2026.
  • Business Quant data shows CRLBF's Total Non-Current Liabilities at $856.5 million in Q1 2026, $844.6 million in Q4 2025, and $842.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn 856.48 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 856.48 Mn
Dec 31, 2025 844.62 Mn
Sep 30, 2025 842.79 Mn
Jun 30, 2025 885.52 Mn
Mar 31, 2025 875.34 Mn
Dec 31, 2024 872.84 Mn
Sep 30, 2024 859.00 Mn
Jun 30, 2024 846.66 Mn
Mar 31, 2024 730.94 Mn
Dec 31, 2023 730.16 Mn
Sep 30, 2023 712.41 Mn
Jun 30, 2023 726.61 Mn
Mar 31, 2023 710.63 Mn
Dec 31, 2022 740.14 Mn
Sep 30, 2022 714.28 Mn
Jun 30, 2022 689.20 Mn
Mar 31, 2022 690.00 Mn
Dec 31, 2021 694.33 Mn
Sep 30, 2021 648.42 Mn
Mar 31, 2021 420.14 Mn